# FDA recall D-0241-2026

> **Merck Sharp & Dohme LLC** · Class II · drug recall initiated 2025-12-12.

## Product

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by:  Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

## Reason for recall

Presence of particulate matter: potential presence of metal particulates in the product.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0241-2026
- **Recalling firm:** Merck Sharp & Dohme LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-12-12
- **Report date:** 2025-12-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilson, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0241-2026

## Citation

> AI Analytics. FDA recall D-0241-2026. Retrieved 2026-07-07 from https://api.ai-analytics.org/recall/D-0241-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*